International Journal of Health Policy and Management

International Journal of Health Policy and Management

Ten Years of Insights on Monitoring the Corporate Political Activity of the Food and Beverage Industry: A Snowballing-Based Literature Review

Document Type : Review Article

Authors
1 Athena Institute, Faculty of Science, Vrije Universiteit, Amsterdam, The Netherlands
2 Epidemiology & Data Science, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands
3 Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
4 Upstream Team, Amsterdam University Medical Centers, Amsterdam, The Netherlands
5 Institut Polytechnique UniLaSalle, Beauvais, France
6 Inserm, Université Paris Cité, Paris, France
Abstract
Background
The commercial practices of the food and beverage industry contribute to ill-health. The industry actively opposes efforts to address this threat to public health through “corporate political activity” (CPA). In 2015, a tool for monitoring CPA through publicly available information was published, and has since then been applied in various countries. This study explores (1) what CPA have been identified, for which contexts and corporate actors, by this tool, and (2) what challenges were encountered for using the tool and how these were addressed.

Methods
A snowballing-based systematic literature review was performed on articles applying the tool to monitor food or beverage industry CPA. The results and discussion sections of included articles were coded qualitatively. Furthermore, original data on specific corporate actors were retrieved from included articles and qualitatively coded.

Results
Twenty articles were included, primarily covering Latin America (n = 11) and the processed foods industry (n = 13), including baby foods and sugar-sweetened drinks. The main challenges for the tool were (1) its labourintensiveness in time and resources, and (2) the limitations and biases of publicly available information. The most
widespread CPA were: spreading favourable evidence (n = 20), accessing policy-making (n = 19), and securing support beyond business (n = 19). Rarest were framing the (actions of) the industry as “legal,” dismissing health harms (n = 1), managing policy venues (n = 0), and coordinating industry strategies (n = 0).

Conclusion
We provide an overview of the reported CPA across the included articles and zoom in on specific corporate actors and actor groups. We provide recommendations on how to strengthen the tool. These include using supplemental interviews to address the limitations of publicly available information and leveraging citizen science and technological solutions to enhance the efficiency of data gathering or analysis, although this carries feasibility, ethics, and bias risks.
Keywords

1.     Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023;401(10383):1194-1213. doi:10.1016/S0140-6736(23)00013-2 
2.     Swinburn BA, Kraak VI, Allender S, et al. The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019;393(10173):791-846. doi:10.1016/S0140-6736(18)32822-8 
3.     Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med. 2012;9(6):e1001235. doi:10.1371/journal.pmed.1001235  
4.     Phelps NH, Singleton RK, Zhou B, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027-1050. doi:10.1016/S0140-6736(23)02750-2 
5.     Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the Preventable Burden of NCD. Glob Heart. 2016;11(4):393-393. doi:10.1016/j.gheart.2016.10.024 
6.     Pfister K. New #CokeLeak: Coca-Cola’s Policy Priorities. 2016; https://medium.com/cokeleak/new-email-leak-coca-cola-policy-priorities-390eb1dfda82.  Accessed September 19, 2024.
7.     Hagenaars LL, Mackenbach JD. How to disrupt harmful corporate political activity? Comment on “Corporate political activity: taxonomies and model of corporate influence on public policy.” Int J Health Policy Manag. 2025;14:9118. doi:10.34172/ijhpm.9118 
8.     Ulucanlar S, Lauber K, Fabbri A, et al. Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy. Int J Health Policy Manag. 2023;12(1):1-22. doi:10.34172/ijhpm.2023.7292 
9.     Brown LW, Rasheed AA, Bell RG. How and Why? A Review of Corporate Political Activity Predictors and Actions. Group Organ Manag. 2022; 47(2):440-484. doi:10.1177/10596011221085200 
10. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, et al. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020; 10(7):e034082. doi:10.1136/bmjopen-2019-034082 
11. Mialon M, Swinburn B, Sacks G. A proposed approach to systematically identify and monitor the corporate political activity of the food industry with respect to public health using publicly available information. Obes Rev. 2015;16(7):519-530. doi:10.1111/obr.12289 
12. Bero L. Implications of the Tobacco Industry Documents for Public Health and Policy. Annu Rev Public Health. 2003;24:267-288. doi:10.1146/annurev.publhealth.24.100901.140813 
13. Mialon M, Swinburn B, Wate J, Tukana I, Sacks G. Analysis of the corporate political activity of major food industry actors in Fiji. Global Health. 2016;12(1):18. doi:10.1186/s12992-016-0158-8  
14. Mialon M, Charry DAG, Cediel G, Crosbie E, Scagliusi FB, Tamayo EMP. “The architecture of the state was transformed in favour of the interests of companies”: corporate political activity of the food industry in Colombia. Global Health. 2020;16:97. doi:10.1186/s12992-020-00631-x 
15. Cetthakrikul N, Baker P, Banwell C, Kelly M, Smith J. Corporate political activity of baby food companies in Thailand. Int Breastfeed J. 2021;16:94. doi:10.1186/s13006-021-00437-6 
16. Wohlin C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. Paper presented at: Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering - EASE ‘14; 2014; New York, New York, USA.
17. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160 
18. Kmet LM, Cook LS, Lee RC. Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields. Alberta Heritage Foundation for Medical Research; 2004.
19. Malkan S. Food industry lobby group ILSI rebrands (again) to duck critical news coverage. 2022. https://usrtk.org/industry-pr/ilsi-rebrands-again/. 
20. Mialon M, Ho M, Carriedo A, Ruskin G, Crosbie E. Beyond nutrition and physical activity: food industry shaping of the very principles of scientific integrity. Glob Health. 2021;17(1):37. doi:10.1186/s12992-021-00689-1 
21. Mialon M, Swinburn B, Allender S, Sacks G. Systematic examination of publicly-available information reveals the diverse and extensive corporate political activity of the food industry in Australia. BMC Public Health. 2016;21:1172. doi:10.1186/s12889-021-10997-1 
22. Mialon M, Mialon J. Corporate political activity of the dairy industry in France: an analysis of publicly available information. Public Health Nutr. 2017;20(13):2432-2439. doi:10.1017/S1368980017001197 
23. Jaichuen N, Phulkerd S, Certthkrikul N, Sacks G, Tangcharoensathien V. Corporate political activity of major food companies in Thailand: an assessment and policy recommendations. Global Health. 2018;14(1):115. doi:10.1186/s12992-018-0432-z 
24. Mialon M, Mialon J. Analysis of corporate political activity strategies of the food industry: evidence from France. Public Health Nutr. 2018; 21(18):3407-3421. doi:10.1017/S1368980018001763  
25. Mialon M, Gomes FdS. Public health and the ultra-processed food and drink products industry: corporate political activity of major transnationals in Latin America and the Caribbean. Public Health Nutr. 2019;22(10):1898-1908. doi:10.1017/S1368980019000417 
26. Paixao MM, Mialon M. Help or Hindrance? The alcohol industry and alcohol control in Portugal. Int J Environ Res Public Health. 2019;16(22):4554. doi:10.3390/ijerph16224554 
27. Mialon M, Charry DAG, Cediel G, Crosbie E, Scagliusi FB, Tamayo EMP. ‘I had never seen so many lobbyists’: food industry political practices during the development of a new nutrition front-of-pack labelling system in Colombia. Public Health Nutr. 2020;24(9):2737-2745. doi:10.1017/s1368980020002268 
28. Mialon M, Corvalan C, Cediel G, Scagliusi FB, Reyes M. Food industry political practices in Chile: “the economy has always been the main concern.” Global Health. 2020;16:107. doi:10.1186/s12992-020-00638-4 
29. Mialon M, Crosbie E, Sacks G. Mapping of food industry strategies to influence public health policy, research and practice in South Africa. Int J Public Health. 2020;65(7):1027-1036. doi:10.1007/s00038-020-01407-1  
30. Mialon M, Khandpur N, Mais LA, Martins APB. Arguments used by trade associations during the early development of a new front-of-pack nutrition labelling system in Brazil. Public Health Nutr. 2020;24(4):766-774.
31. Mialon M, Pinsky I. Food industry responding to the COVID-19 pandemic in Brazil: public health or public relations? World Nutrition. 2020;13(1):2-75.
32. Ojeda E, Torres C, Carriedo A, Mialon M, Parekh N, Orozco E. The influence of the sugar-sweetened beverage industry on public policies in Mexico. Int J Public Health. 2020;65(7):1037-1044. doi:10.1007/s00038-020-01414-2 
33. Tanrikulu H, Neri D, Robertson A, Mialon M. Corporate political activity of the baby food industry: the example of Nestle in the United States of America. Int Breastfeed J. 2020;15:22. doi:10.1186/s13006-020-00268-x 
34. Cossez E, Baker P, Mialon M. ‘The second mother’: How the baby food industry captures science, health professions and civil society in France. Matern Child Nutr. 2021;18(2):e13301. doi:10.1111/mcn.13301 
35. Mialon M, Cediel G, Jaime PC, Scagliusi FB. “A consistent stakeholder management process can guarantee the ‘social license to operate”: mapping the political strategies of the food industry in Brazil. Cadernos De Saude Publica. 2021;37(Suppl 1):e00085220. doi:10.1590/0102-311x00085220 
36. Kroker-Lobos MF, Morales LA, Ramírez-Zea M, Vandevijvere S, Champagne B, Mialon M. Two countries, similar practices: the political practices of the food industry influencing the adoption of key public health nutrition policies in Guatemala and Panama. Public Health Nutr. 2022; 25(11):3252-3264. doi:10.1017/s1368980022001811 
37. Robles CAP, Mialon M, Mais LA, Neri D, Silva KC, Baker P. Breastfeeding, first-food systems and corporate power: a case study on the market and political practices of the transnational baby food industry in Brazil. Global Health. 2024;20:12. doi:10.1186/s12992-024-01016-0 
38. Steele S, Ruskin G, Sarcevic L, McKee M, Stuckler D. Are industry-funded charities promoting “advocacy-led studies” or “evidence-based science”?: a case study of the International Life Sciences Institute. Global Health. 2019;15(1):36. doi:10.1186/s12992-019-0478-6 
39. Fooks GJ, Williams S, Box G, Sacks G. Corporations’ use and misuse of evidence to influence health policy: a case study of sugar-sweetened beverage taxation. Glob Health. 2019;15:56. doi:10.1186/s12992-019-0495-5 
40. Abdool Karim S, Petronell K, Natasha M, Agnes E, Susan G, and Hofman K. Stakeholder arguments during the adoption of a sugar sweetened beverage tax in South Africa and their influence: a content analysis. Global Health Action. 2023;16(1):2152638. doi:10.1080/16549716.2022.2152638 
41. Ulucanlar S, Fooks GJ, Gilmore AB. The policy dystopia model: an interpretive analysis of tobacco industry political activity. PLoS Med. 2016; 13:e1002125. doi:10.1371/journal.pmed.1002125 
42. McCambridge J, Coleman R, McEachern J. Public health surveillance studies of alcohol industry market and political strategies: a systematic review. J Stud Alcohol Drugs. 2019;80(2):149-157. doi:10.15288/jsad.2019.80.149 
43. Assunta M, Dorotheo EU. SEATCA Tobacco Industry Interference Index: a tool for measuring implementation of WHO Framework Convention on Tobacco Control Article 5.3. Tob Control. 2016;25(3):313-318. doi:10.1136/tobaccocontrol-2014-051934 
44. Brown MA, Gruen A, Maldoff G, Messing S, Sanderson Z, Zimmer M. Web scraping for research: Legal, ethical, institutional, and scientific considerations. Big Data Soc. 2025;12(4):20539517251381686. doi:10.1177/20539517251381686 
45. Ayuso E, Brogya MSD, Ahlawat VK, Sain M. From Manual to Machine: How AI is Redefining Web Scraping for Superior Efficiency: A Literature Review. Paper presented at: 2024 International Conference on Communication, Control, and Intelligent Systems (CCIS); December 6-7, 2024.
46. Schueller T, Trettin A, Huber S. Evaluating AI-assisted deductive coding in MAXQDA: a methodological analysis of inputs and outputs. Int J Qual Methods. 2026;25:16094069251407046. doi:10.1177/16094069251407046 
47. Xiao Z, Yuan X, Liao QV, Abdelghani R, Oudeyer P-Y. Supporting qualitative analysis with large language models: combining codebook with GPT-3 for deductive coding. Companion Proceedings of the 28th International Conference on Intelligent User Interfaces. Sydney, NSW, Australia: Association for Computing Machinery; 2023:75-78.
48. Parker RD, Mancini K, Abram MD. Natural Language processing enhanced qualitative methods: an opportunity to improve health outcomes. Int J Qual Methods. 2023;22:16094069231214144. doi:10.1177/16094069231214144 
49. Cheligeer C, Yang L, Nandi T, et al. Natural language processing (NLP) aided qualitative method in health research. Journal of Integrated Design and Process Science. 2022;27(1):41-58. doi:10.3233/jid-220013 
50. Ashwin J, Chhabra A, Rao V. Using Large Language Models for Qualitative Analysis can Introduce Serious Bias. Sociol Methods Res.2026;55(3):795-839. doi:10.1177/00491241251338246 
51. Linda E. Kruger MAS. Getting to know ourselves and our places through participation in civic social assessment. Soc Nat Resour. 2000;13(5):461-478. doi:10.1080/089419200403866 
52. Whitelaw G, Vaughan H, Craig B, Atkinson D. Establishing the Canadian Community Monitoring Network. Environ Monit Assess. 2003;88(1):409-418. doi:10.1023/A:1025545813057 
53. Conrad CC, Hilchey KG. A review of citizen science and community-based environmental monitoring: issues and opportunities. Environ Monit Assess. 2011;176(1):273-291. doi:10.1007/s10661-010-1582-5 
54. Lacy-Nichols J, Williams O. “Part of the solution”: food corporation strategies for regulatory capture and legitimacy. Int J Health Policy Manag. 2021;10(12):845-856. doi:10.34172/ijhpm.2021.111 
55. Jennifer L-N, Robert M. Power and the commercial determinants of health: ideas for a research agenda. BMJ Glob Health. 2021;6(2):e003850. doi:10.1136/bmjgh-2020-003850 
56. Brownell KD, Warner KE. The Perils of Ignoring History: Big Tobacco Played Dirty and Millions Died. How Similar Is Big Food? Milbank Q. 2009; 87(1):259-294. doi:10.1111/j.1468-0009.2009.00555.x 
57. Power and the commercial determinants of health: ideas for a research agenda. BMJ Glob Health. 2021;6(2):e003850. doi:10.1136/bmjgh-2020-003850 
58. Lacy-Nichols J, Marten R, Crosbie E, Moodie R. The public health playbook: ideas for challenging the corporate playbook. Lancet Glob Health. 2022;10(7):e1067-e1072. doi:10.1016/S2214-109X(22)00185-1 
59. Evans-Reeves KA, Matthes BK, Chamberlain P, Paichadze N, Gilmore AB, Mialon M. Intimidation against advocates and researchers in the tobacco, alcohol and ultra-processed food spaces: a review. Health Promot Int. 2024;39(6):daae153. doi:10.1093/heapro/daae153 
60. Matthes BK, Alebshehy R, Gilmore AB. “They try to suppress us, but we should be louder”: a qualitative exploration of intimidation in tobacco control. Glob Health. 2023;19(1):88. doi:10.1186/s12992-023-00991-0 
61. Milsom P, Smith R, Baker P, Walls H. Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review. Health Policy Plan. 2021;36(4):493-508. doi:10.1093/heapol/czaa148 
62. Matthes BK, Lauber K, Zatoński M, Robertson L, Gilmore AB. Developing more detailed taxonomies of tobacco industry political activity in low-income and middle-income countries: qualitative evidence from eight countries. BMJ Glob Health. 2021;6(3):e004096. doi:10.1136/bmjgh-2020-004096 
63. Aguiar Aguilar AA. Courts and the judicial erosion of democracy in Latin America. Politics & Policy. 2023;51(1):7-25. doi:10.1111/polp.12516 
64. Turba R, Thoré ESJ, Bertram MG, et al. Global North-South science inequalities due to language and funding barriers. Peer Community Journal. 2026;6:e9. doi:10.24072/pcjournal.677 
65. Tripathy A, Mahapatra D, Khan H, Khan Z. Twenty-five years of corporate political activity research in Asia: A literature review and research agenda. Asia Pacific Journal of Management. 2026. doi:10.1007/s10490-025-10080-y 
66. Steele S, Ruskin G, Stuckler D. Pushing partnerships: corporate influence on research and policy via the International Life Sciences Institute. Public Health Nutr. 2020;23(11):2032-2040. doi:10.1017/S1368980019005184 
67. Griffin S. Coca-Cola’s work with academics was a “low point in history of public health.” BMJ. 2020;370:m3075. doi:10.1136/bmj.m3075 
68. Toenshoff CL. Collective irresponsibility: corporate reputations and the role of associations in lobbying. Bus Polit. 2025;28(2):319-341. doi:10.1017/bap.2025.14 
69. Vesa J, Hanegraaff M, Binderkrantz AS, Vehka M. Why firms lobby more alone than collectively: a systematic test across three countries. J Eur Public Policy. 2025;33(7):1841-1864. doi:10.1080/13501763.2025.2512033 
70. Hillman AJ, Hitt MA. Corporate Political Strategy Formulation: A Model of Approach, Participation, and Strategy Decisions. Acad Manage Rev. 1999;24(4):825-842. doi:10.2307/259357 
71. Nestlé document says majority of its food portfolio is unhealthy. 2022. https://www.ft.com/content/4c98d410-38b1-4be8-95b2-d029e054f492.  Accessed August 27, 2025.
72. Narain A, Kwok CS, Mamas MA. Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract. 2016;70(10):791-805. doi:10.1111/ijcp.12841 
73. Tahmassebi JF, BaniHani A. Impact of soft drinks to health and economy: a critical review. Eur Arch Paediatr Dent. 2020;21(1):109-117. doi:10.1007/s40368-019-00458-0 

Articles in Press, Corrected Proof
Available Online from 02 November 2026

Supplementary File
(IJHPM does not take responsibility for any information provided in the supplementary files.)

  • Received Date 22 October 2025
  • Revised Date 21 September 2026
  • Accepted Date 01 November 2026
  • First Published Date 02 November 2026
  • Published Date 02 November 2026